Implied preemption makes complete sense when it is evident that the FDA would not have permitted label changes that plaintiffs in private litigation s
Continue Reading Preemption Found in Another Drug MDL
regulatory
Advisory Group Recommends Cost/Benefit Analysis for CPSC Regulations
By Sean Wajert on
Posted in Articles
We have posted before about the impact of regulations on clients and indirectly on product litigation. Earlier this month the Administrative Conferenc…
Continue Reading Advisory Group Recommends Cost/Benefit Analysis for CPSC Regulations
Report Issued on Use of Science in Regulatory Decisions
By Sean Wajert on
Scientists and policy experts from industry, government, and various nonprofit sectors worked on a report released recently by the Research Integrity …
Continue Reading Report Issued on Use of Science in Regulatory Decisions
U.S. Chamber Describes Tort Reform Goals for 2012
By Sean Wajert on
Posted in Articles
Here at MassTortDefense we try to keep at least one eye on important tort reform efforts, and how they may impact the litigation that we blog about. T…
Continue Reading U.S. Chamber Describes Tort Reform Goals for 2012
Regulatory Reform Bills Pass House
By Sean Wajert on
Posted in Articles
We have posted before about legislative attempts to limit the harmful effects of excessive federal regulation on product sellers. Readers know how tho…
Continue Reading Regulatory Reform Bills Pass House
House Committee Tackles Regulations
By Sean Wajert on
Posted in Articles
The House Judiciary Committee held a hearing last week on a bill that would require federal agencies to evaluate the costs of proposed regulations bef…
Continue Reading House Committee Tackles Regulations
Multi-State Coalition On Chemicals Management Formed
By Sean Wajert on
Readers have been following our posts on new state efforts on chemical regulation, such as California’s Green Chemistry initiative. Now comes word tha…
Continue Reading Multi-State Coalition On Chemicals Management Formed
EPA Releases First Chemical Action Plan
By Sean Wajert on
The Environmental Protection Agency recently issued its first Chemical Action Plan (CAP). The plan deals with phthalates, which are found in some food…
Continue Reading EPA Releases First Chemical Action Plan
IOM To Study 510(k) Process for Medical Devices
By Sean Wajert on
Posted in Articles, Drug and Device
The U.S. Food and Drug Administration announced recently that it had commissioned the Institute of Medicine (IOM) to study the premarket notification …
Continue Reading IOM To Study 510(k) Process for Medical Devices